An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

Stratifying body mass index categories by waist circumference thresholds improves mortality risk prediction in postmenopausal women.

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.

For young adults, body fat percentage is a better predictor of 15-year mortality risk than body mass index (BMI).

A new British Nutrition Foundation review finds that most UK women of reproductive age fall short of key nutrients before and ...